Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X antigen family member 1B (XAGE1B) is a member of the cancer-testis (CT) antigen family, specifically the XAGE subfamily, within the broader GAGE gene family[5][4]. It encodes a nuclear protein, produced predominantly in the testis and various tumor types—notably lung adenocarcinoma, Ewing's sarcoma, rhabdomyosarcoma, and hepatocellular carcinoma[6][4][5]. There are multiple transcript variants of the XAGE-1 gene (a, b, c, d, e), but XAGE-1b is the dominantly expressed cancer-associated variant[2][6]. The protein is highly immunogenic in cancer patients and contains a nuclear localization signal[6][4]. Expression in normal tissue is highly restricted to the testis; it is otherwise nearly undetectable outside of tumors[6][4]. Functional ly, the gene is annotated for protein binding, with potential involvement in cell signaling and complex formation, though its precise molecular role remains poorly defined[3][6]. XAGE1B is studied as both a possible diagnostic and prognostic biomarker in cancer—particularly for hepatocellular carcinoma, where serum XAGE-1b mRNA has been shown to have high sensitivity and specificity[2]. Its expression is linked with aggressive clinical features and disease recurrence in this context. No specific drugs targeting XAGE1B are currently described, but as a cancer-testis antigen, it is a potential target for cancer immunotherapy, such as cancer vaccines or adoptive T-cell therapies[6][2][5]. The restricted tissue distribution suggests a potentially favorable therapeutic window, but the functional effects and safety of XAGE1B-directed interventions are not yet well defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X antigen family member 1B (XAGE1B).